z-logo
open-access-imgOpen Access
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
Author(s) -
Huanhuan Zhao,
Jun Lu,
Yan Tong,
Fei Han,
Jie Sun,
Xiaolin Yin,
Liting Cheng,
Chao Shen,
Mark Wunderlich,
Weina Yun,
Ling–Ling Yang,
Liyun Chen,
Dan Su,
Stefan K. Bohlander,
Fudi Wang,
James C. Mulloy,
Chong Li,
Jianjun Chen,
He Huang,
Xi Jiang
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.110253
Subject(s) - myeloid leukemia , pharmacology , cancer research , opioid receptor , opioid , leukemia , biology , receptor , agonist , chemistry , immunology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom